5.20Open5.20Pre Close0 Volume1 Open Interest2.50Strike Price0.00Turnover808.75%IV-46.90%PremiumMay 16, 2025Expiry Date12.00Intrinsic Value100Multiplier13DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9718Delta0.0029Gamma1.16Leverage Ratio-0.0544Theta0.0006Rho1.13Eff Leverage0.0018Vega
Bicara Therapeutics Stock Discussion
Breakthrough Cancer Drug Data: Bicara's Dual-Acting Treatment Takes On Aggressive Head & Neck Cancer
No comment yet